Curriculum

PGY1

• Alcohol use disorder screening and treatment w/Dr. Katherine Mullins

  • PREP

• Advance Care Planning for Community-Dwelling Adults w/ Dr. Carol Kelly

• Benzodiazepines and Sedatives w/ Dr. Kristine Torres-Lockhart

• Buprenorphine Prescribing

  • NYS DOH Treatment Guidelines for Opioid Use Disorder

• Cancer Screening w/ Dr. Darlene LeFrancois

  • List of useful screening and prevention resources

  • Pre-test 

• Clinical Research Introduction w/Dr. Cowman

• Chronic Cough by Dr. Rivkah Darabaner

• Contraception

• COPD w/ Dr. Daniel Fein (2020)

• COPD w/ Dr. Marjan Islam (2021)

• Dementia with Dr. Chalmer

  • PREP  

• Diabetes 101 w/ Tammy Tavdy

• Diabetes 102 w/ Dr. Louard 

• Diagnostic Verification with Dr. Serena Roth

  • PREP #1 

  • PREP #2 

• Efficiency in Clinic w/Dr. Michael Castellot

• Financial Wellness w/ Dr. Jing Pan

• Genetic/Cancer Screening in Special Populations w/ Dr. Sara Rabin-Havt

• Harm Reduction w/ Dr. Ben Hayes 

  • PREP: Please read any 2 of the 4 articles below

  • #1

  • #2

  • #3

  • #4

• Health and Housing w/Dr. Marc Shi

• How to Search the Medical Literature w/ Dr. Michael Bogaisky

• Hyperlipidemia

  • PREP

    • Pre-Test

    • AHA/ACC Hyperlipidemia Guideline Algorithm (2018)

    • Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort (AJC 2016)

    • Statin Use for the Primary Prevention of Cardiovascular Disease in Adults : USPSTF (JAMA 2016)

  • Additional, optional reading and resources

    • Optional Reading: Trending Cardiovascular Nutrition Controversies (JACC 2017)

    • Full AHA/ACC 2018 Guidelines

• ID in the Ambulatory Setting w/ Dr. Priya Nori

• Immunizations w/ Dr. Jamie Osman

• Intimate Partner Violence w/Dr. Ana Valle

• Intro to Scholarly Activity and Career Development w/ Dr. Johanna Daily

• Library Resources w/ Marie Elias

• Medical Marijuana and article

• Nutrition 

• Opioid Use Disorder Prevention and Opioid Overdose Prevention with Dr. Tiffany Lu

• Outpatient Care of Adults with Sickle Cell Disease by Dr. Susanna Curtis

• Psychiatry in the Primary Care Setting

• Reasoning without resources

  • RWR #1

  • RWR #2

• Serious Illness Conversation w/Dr. Clark, Dr. Swiderski, and Dr. Jain

  • Session #1

  • Session #2

• Social Determinants of Health

  • General Community Resources

• STIs w/ Dr. Lauren Shapiro

• Women's Mental Health w/Dr. Vaughn

PGY2

• QI Curriculum

  • • Session #1

      • PREP (Pages 1-3 only!)

      • Epic Tips

    • Session #2 

      • PREP: 

        • Make a Monte box account

        • Be prepared with a few potential topics for year-long projects 

    • Session #3

      • Enter the session with a SMART goal and intervention

      • If intervention has already been applied, come ready to discuss lessons learned

    • Session #4-6

      • Data collection for project

      • Come prepared to discuss how intervention is going, lessons learned, etc. 

• Advance Care Planning for Community-Dwelling Adults: How Primary Care Physicians Can Help Our Most Seriously Ill Patients Have Their Health Care Wishes Honored w/ Dr. Carol Kelly

  • MOLST form

  • Serious Illness Conversation Guide

• Amenorrhea

  • Required Readings

    • Questions

    • Endocrine disorders in women

    • Hirsutism

  • Additional Resources

    • Turner's Syndrome 

    • PCOS

• Diagnosis w/Dr. Will Preston

  • Prep work

    • Labratory diagnosis of iron-deficiency anemia (abstract only)

    • D-dimer interval likelihod ratios for pulmonary embolish (abstract only)

  • Worksheet for session

  • Further reading

• Global Burden of Disease - CV - cases and questions

• Health Care Systems  w/ Dr. Anne Marie Reynolds

• Hypercalcemia with Dr. Tabatabaie 

• LP session w/ Dr. Benjamin Galen

  • LP video and post-test

  • LP checklist

  • Anticoagulation and beside procedures

• Outpatient Care of Adults with Sickle Cell Disease by Dr. Susanna Curtis

• Principles of Screening w/ Darlene LeFrancois

  • • Learning Objectives

    • Clinical Epi chapter - Fletcher

    • Clinical Epi chapter - Sackett

    • Welch 5-yr survival paper (needed in order to answer the third question (last question before the cases) in the pre-test below)

    • Pre-test

• Reasoning without resources

  • RWR #3

• Social Determinants of Health Tweetorial w/Dr. Sunit Jariwala

  • PREP

  • Optional additional reading

• Social Determinants of Health Workshop w/ Dr. Iman Hassan

•  Survival Analysis w/Dr. Jonathan Ross

  • PREP

• Asking, Listening & Doing What Matters: Addressing Social Determinants of Health Stressors  with Dr. Damara Gutnick

  • Additional Resources

    • Mr. Smith's Smoking Evolution MI Story 

    • WMTY website where you can sign up for monthly meetings

• Motivational Interviewing for Vaccine Hesitancy with Dr. Damara Gutnick 

PGY3

• Aspirin Prevention w/ Dr. Erin Goss

  • PREP

    • JAMA: Aspirin Use for Primary Prevention - USPSTF recommendations

    • Article

    • Questions

  • Additional Readings

    • ARRIVE trial

    • ASCEND trial

    • ASPREE trial

• Clinical Prediction Rules and Prognosis w/ Dr. Shudan Wang

  • PREP

    • Article

    • Primer (Section 9 only)

  • For session

    • Questions

• Clinical EPI: Diagnosis w/ Dr. Joe Deluca

  • Reading and Prep

• Cervical Cancer Screening w/ Dr. Lauren Shapiro

Questions (the numbers next to the questions correspond with the articles below)

# 6: HPVmenQALYs

# 5: HPV vaccine women

# 4: Cervical cancer screening follow up

# 3: Athena study; HPV first line screening

# 2: Cervical Cancer Screening Reference Guide

# 1: Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement

• Colon Cancer Screening w/ Dr. Darlene LeFrancois

  • Required PREP

    • Objectives 

    • Questions 

  • Required readings (read only what is in parentheses): 

    • US multi society task force - surveillance in colorectal cancer (skim full article)

    • USPSTF Statement (2021) (skim full article)

    • Atkins, Risk After Excision (skim full article)

    • Winawer, Survelliance Intervals  (abstract only)

    • Imperiale, Risk of Proximal Neoplasm (abstract and table 2)

    • Lieberman, CRCa screening (title only)

  • References

    • OBrien, National Polyp Study (table 1, WHO histologic class)

    • Hardcastle, FOB screening (abstract)

    • Mandel, Fecal Occult Blood Screening (abstract)

    • Kornborg, FOB screening (abstract)

    • Winamer, Polypectomy

    • Elmunzer, Flex Sig RCT meta-analysis 2012

• Lung Cancer Screening w/ Dr. Shwetha Iyer

  • To be discussed during lecture:

    • NLST trial NEJM 2011

    • Cost effectiveness

  • Supplemental Reading/References:

    • Lung Cancer Screening Decision Aid

    • Who should be screened for lung cancer and who should decide

    • Starting a new discussion about screening for lung cancer

• Hypertension 301 w/ Dr. Molly Fisher

• Observational Studies w/ Dr. Matthew Abramowitz

• PREP (review these articles)

  • NEJM Coffee & Pancreatic Cancer

  • Observational Studies 2019

  • Observational Studies Bias and causal assessment

  • Observational Studies Case Control article

  • Observational Studies cohort studies article

  • Observational studies Nuts article

• Osteoporosis w/ Dr. Tabatabaie  Osteoporosis 2021

  • PREP 

• Preconception Planning w/ Dr. Ellen Harrison

  • PREP

    • 2019 ADA article on Management of Diabetes in Pregnancy

• Prostate Cancer Screening w/ Dr. Darlene LeFrancois

  • Required PREP

    • European trial

    • PLCO

  • Supplemental articles/Resources

    • Catalona (read article)

    • Johansson (read abstract, tables)

    • JAMA Complication Rates (read abstract)

    • Montefiore Decision Aid

    • Montefiore Surveillance Interval Guide  

  • References

    • Rad Pros vs Watch Wait

    • QALY 2012 NEJM 

    • USPSTF Prostate CA Screening Guidelines (2018)

    • USPSTF Prostate CA Screening Guidelines (2012)

    • Lawsuit JAMA 2004 

    • An ISUP Concensus on Contemporary Grading

      • The 3 group Gleason categorization is the traditional categorization of prostate cancer pathology (well diff score 2-4, mod diff score 5-7, poor diff score 8-10) but many emerging predictive models around prognosis now utilize this newer ISUP Grading which results in a 5-category grouping of pathology.  This is part of a growing attempt to avoid overtreating men with screen-detected prostate cancer by identifying low risk patients suitable for active surveillance (AS) rather than subjecting them to radical prostatectomy (RP) or radiation therapy.   

• Telemedicine w/ Dr. Maria Duda

  • ACP Module on Telehealth